About

White House Releases 2026 National AI Policy Framework on March 20

Published
Score
16

Why it matters

On March 20, 2026, the White House released the National Policy Framework for Artificial Intelligence, proposing federal legislation to preempt state laws that impose "undue burdens" on AI deployment. The framework aims to establish uniform national standards for AI governance across sectors, particularly healthcare, where the technology is rapidly expanding into clinical decision support, diagnostics, and administrative workflows. The initiative follows a December 2025 Executive Order directing the administration to develop coordinated federal policy. Implementation would distribute oversight among existing agencies—the FDA, CMS, HHS, OCR, FTC, and DOJ—rather than creating a new regulatory body. The Department of Commerce would evaluate conflicting state laws.

The framework arrives amid a fragmented regulatory landscape. Over 250 state AI-related bills were introduced in 2025, with 177 pending across 31 states as of April 2026. These state measures—including Colorado's AI Act, California's AB 3030, Utah's AI Act, and Illinois restrictions on AI in psychotherapy—address bias, disclosure requirements, informed consent, and clinician accountability. No federal preemptive legislation has yet passed, meaning existing state laws remain in force. Legal challenges to both state and federal approaches are anticipated.

For healthcare practitioners and digital health companies, the stakes are immediate. The framework proposes compliance flexibilities and regulatory sandboxes to encourage innovation, but attorneys should monitor whether preemption legislation advances and how courts resolve conflicts between state and federal standards. Uniform compliance requirements could streamline deployment across state lines, but the outcome remains uncertain. Providers should track both federal legislative progress and pending state bills, particularly those addressing AI use in high-stakes decisions like prior authorizations and drug discovery, where liability exposure is greatest.

mail Subscribe to Health Care email updates

Primary sources. No fluff. Straight to your inbox.

Also on LawSnap